RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise in ovarian cancer fight
Disease control OngoingThis study tests whether adding oregovomab to niraparib can help control platinum-sensitive recurrent ovarian cancer. Ten adults with this type of cancer will receive both drugs. The goal is to see if the combination shrinks tumors or stops them from growing, while monitoring sid…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New hope for recurrent ovarian and uterine cancer? early trial launches
Disease control OngoingThis early-phase study tests a new drug (RP-6306) combined with two standard chemotherapies for people with recurrent ovarian or uterine cancer that has a specific gene change (TP53 mutation). The main goals are to find the safest dose and see if the combination can shrink tumors…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 11, 2026 20:37 UTC